Carcinoma, squamous cell Trials in Boston, United States
Conditions / Carcinoma, squamous cell / Boston, United States
Clinical trials for Carcinoma, squamous cell investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01345682 | LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy | COMPLETED | PHASE3 |
| NCT00847912 | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial | COMPLETED | PHASE4 |
| NCT02666833 | Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers | UNKNOWN | — |
| NCT00272181 | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | TERMINATED | PHASE2 |
| NCT04892173 | JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | RECRUITING | — |
| NCT00358930 | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck | COMPLETED | PHASE2 |
| NCT03906526 | A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer | TERMINATED | PHASE1 |
| NCT06295809 | A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT04429542 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT03833167 | Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) | COMPLETED | PHASE3 |